Details

Autor(en) / Beteiligte

• de Hoog, Sybren
• Walsh, Thomas J
• Ahmed, Sarah A
• Alastruey-Izquierdo, Ana
• Alexander, Barbara D
• Arendrup, Maiken Cavling
• Babady, Esther
• Bai, Feng-Yan
• Balada-Llasat, Joan-Miquel
• Borman, Andrew
• Chowdhary, Anuradha
• Clark, Andrew
• Colgrove, Robert C
• Cornely, Oliver A
• Dingle, Tanis C
• Dufresne, Philippe J
• Fuller, Jeff
• Gangneux, Jean-Pierre
• Gibas, Connie
• Glasgow, Heather
• Gräser, Yvonne
• Guillot, Jacques
• Groll, Andreas H
• Haase, Gerhard
• Hanson, Kimberly
• Harrington, Amanda
• Hawksworth, David L
• Hayden, Randall T
• Hoenigl, Martin
• Hubka, Vit
• Johnson, Kristie
• Kus, Julianne V
• Li, Ruoyu
• Meis, Jacques F
• Lackner, Michaela
• Lanternier, Fanny
• Leal, Jr, Sixto M
• Lee, Francesca
• Lockhart, Shawn R
• Luethy, Paul
• Martin, Isabella
• Kwon-Chung, Kyung J
• Meyer, Wieland
• Nguyen, M Hong
• Ostrosky-Zeichner, Luis
• Palavecino, Elizabeth
• Pancholi, Preeti
• Pappas, Peter G
• Procop, Gary W
• Redhead, Scott A
• Rhoads, Daniel D
• Riedel, Stefan
• Stevens, Bryan
• Sullivan, Kaede Ota
• Vergidis, Paschalis
• Roilides, Emmanuel
• Seyedmousavi, Amir
• Tao, Lili
• Vicente, Vania A
• Vitale, Roxana G
• Wang, Qi-Ming
• Wengenack, Nancy L
• Westblade, Lars
• Wiederhold, Nathan
• White, Lewis
• Wojewoda, Christina M
• Zhang, Sean X

Titel

A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC

Ist Teil von

• Journal of clinical microbiology, 2023-11, Vol.61 (11), p.e0087323

Ort / Verlag

United States

Erscheinungsjahr

2023

Link zum Volltext

Beschreibungen/Notizen

• The rapid pace of name changes of medically important fungi is creating challenges for clinical laboratories and clinicians involved in patient care. We describe two sources of name change which have different drivers, at the species versus the genus level. Some suggestions are made here to reduce the number of name changes. We urge taxonomists to provide diagnostic markers of taxonomic novelties. Given the instability of phylogenetic trees due to variable taxon sampling, we advocate to maintain genera at the largest possible size. Reporting of identified species in complexes or series should where possible comprise both the name of the overarching species and that of the molecular sibling, often cryptic species. Because the use of different names for the same species will be unavoidable for many years to come, an open access online database of the names of all medically important fungi, with proper nomenclatural designation and synonymy, is essential. We further recommend that while taxonomic discovery continues, the adaptation of new name changes by clinical laboratories and clinicians be reviewed routinely by a standing committee for validation and stability over time, with reference to an open access database, wherein reasons for changes are listed in a transparent way.